Literature DB >> 32259065

Lymphatic Function and Dysfunction in the Context of Sex Differences.

Claire E Trincot1, Kathleen M Caron1.   

Abstract

Endothelial cells are the building blocks of the blood vascular system and exhibit well-characterized sexually dimorphic phenotypes with regard to chromosomal and hormonal sex, imparting innate genetic and physiological differences between male and female vascular systems and cardiovascular disease. However, even though females are predominantly affected by disorders of lymphatic vascular function, we lack a comprehensive understanding of the effects of sex and sex hormones on lymphatic growth, function, and dysfunction. Here, we attempt to comprehensively evaluate the current understanding of sex as a biological variable influencing lymphatic biology. We first focus on elucidating innate and fundamental differences between the sexes in lymphatic function and development. Next, we delve into lymphatic disease and explore the potential underpinnings toward bias prevalence in the female population. Lastly, we incorporate more broadly the role of the lymphatic system in sex-biased diseases such as cancer, cardiovascular disease, reproductive disorders, and autoimmune diseases to explore whether and how sex differences may influence lymphatic function in the context of these pathologies.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 32259065      PMCID: PMC7089000          DOI: 10.1021/acsptsci.9b00051

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  235 in total

Review 1.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Mechanotransduction in lymphatic endothelial cells.

Authors:  A Rossi; E Weber; G Sacchi; D Maestrini; F Di Cintio; R Gerli
Journal:  Lymphology       Date:  2007-09       Impact factor: 1.286

3.  Prox1 function is required for the development of the murine lymphatic system.

Authors:  J T Wigle; G Oliver
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

4.  Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer.

Authors:  Fusun Ozmen; M Mahir Ozmen; Evren Ozdemir; Munevver Moran; Selda Seçkin; Dicle Guc; Ergun Karaagaoglu; Emin Kansu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

5.  Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.

Authors:  T Veikkola; L Jussila; T Makinen; T Karpanen; M Jeltsch; T V Petrova; H Kubo; G Thurston; D M McDonald; M G Achen; S A Stacker; K Alitalo
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 6.  Mechanisms of lymphatic metastasis.

Authors:  Sinem Karaman; Michael Detmar
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 7.  Sources of estrogen and their importance.

Authors:  E R Simpson
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

8.  Androgens up-regulate atherosclerosis-related genes in macrophages from males but not females: molecular insights into gender differences in atherosclerosis.

Authors:  Martin K C Ng; Carmel M Quinn; Jane A McCrohon; Shirley Nakhla; Wendy Jessup; David J Handelsman; David S Celermajer; Alison K Death
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

Review 9.  The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.

Authors:  Andrea Iorga; Christine M Cunningham; Shayan Moazeni; Gregoire Ruffenach; Soban Umar; Mansoureh Eghbali
Journal:  Biol Sex Differ       Date:  2017-10-24       Impact factor: 5.027

Review 10.  Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases.

Authors:  Rujuan Dai; S Ansar Ahmed
Journal:  Ther Clin Risk Manag       Date:  2014-03-03       Impact factor: 2.423

View more
  5 in total

1.  VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling.

Authors:  Natalie R Harris; Natalie R Nielsen; John B Pawlak; Amir Aghajanian; Krsna Rangarajan; D Stephen Serafin; Gregory Farber; Danielle M Dy; Nathan P Nelson-Maney; Wenjing Xu; Disha Ratra; Sophia H Hurr; Li Qian; Joshua P Scallan; Kathleen M Caron
Journal:  Circ Res       Date:  2021-11-18       Impact factor: 17.367

2.  Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction.

Authors:  T C Stevenson Keller; Lillian Lim; Swapnil V Shewale; Kendra McDaid; Íngrid Martí-Pàmies; Alan T Tang; Carl Wittig; Andrea A Guerrero; Stephanie Sterling; N Adrian Leu; Marielle Scherrer-Crosbie; Phyllis A Gimotty; Mark L Kahn
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

Review 3.  Current Mechanistic Understandings of Lymphedema and Lipedema: Tales of Fluid, Fat, and Fibrosis.

Authors:  Bailey H Duhon; Thien T Phan; Shannon L Taylor; Rachelle L Crescenzi; Joseph M Rutkowski
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

Review 4.  Pharmacological Treatment of Secondary Lymphedema.

Authors:  Stav Brown; Joseph H Dayan; Michelle Coriddi; Adana Campbell; Kevin Kuonqui; Jinyeon Shin; Hyeung Ju Park; Babak J Mehrara; Raghu P Kataru
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

Review 5.  Hypoxia and Hypoxia-Inducible Factors in Lymphedema.

Authors:  Xinguo Jiang; Wen Tian; Dongeon Kim; Alexander S McQuiston; Ryan Vinh; Stanley G Rockson; Gregg L Semenza; Mark R Nicolls
Journal:  Front Pharmacol       Date:  2022-03-28       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.